Endpoints News
Three biotechs raise funds Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M T Wed Th F
12 August, 2026
Announcing our $100M Series B
Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery
sponsored by Aureka Biotechnologies
presented by Ocular Therapeutix
The de­bate of dura­bil­i­ty in nAMD
top stories
1. Post-Hoc: Rewatch the Boston edition of our China Biotech Debate
2.
news briefing
AbCellera, Silence and InduPro all raise significant funding
3. Definium's LSD drug clears bar in first of two Phase 3 anxiety disorder trials
4. Boulevard Bio dreams big in immunology with $65M, sights on Vera's IgAN drug
more stories
 
bioregnum
Karen Weintraub
.

At our China debate last week, MIT Professor Fiona Murray was the voice of reason: “We have to promote this industry. We have to invest in this industry. But we do also have to know where our money is going." Learn more and get details about how to watch here.

.
Karen Weintraub
Deputy Editor, Endpoints News
From L-R: Drew Armstrong, Peter Kolchinsky, Fiona Murray and Jason Kelly at Endpoints' China event in Cambridge, MA (Samantha Barracca for Endpoints News)
1
by Drew Armstrong

Last week, we host­ed the most en­gag­ing event I’ve been a part of here at End­points News.

If you were there, you got to...

Read the full story
Endpoints webinars
Aug 19
1:00 pm ET
From pilots to production: AI across R&D, safety, regulatory, and clinical
IBM
Aug 27
12:00 pm ET
Same molecule, different paths: Where value goes in cross-border dealmaking in a new era
PharmCube
Sep 03
11:00 am ET
How leading pharma organizations are putting AI agents to work
Medable
Endpoints 11 - Reserve Your Spot - Save $100 with our Early Bird rate
One night, one room: the founders, scientists and investors behind the Endpoints 11, together in Boston this September. Reserve your spot now and save with the early bird rate.
News Briefing: Quick hits from the biopharma web
2
by ENDPOINTS

Ab­Celler­a's $200M of­fer­ing: The Van­cou­ver biotech is sell­ing shares af­ter hit­ting the bar in a Phase 2hot flash­es tri­al on Mon­day. The Cana­di­an drug...

Read the full story
Endpoints Careers
Scientist, Drug Discovery Data for AI/ML
D. E. Shaw Research
New York, NY, USA
Machine Learning Researchers and Engineers
D. E. Shaw Research
New York, NY, USA
Recruit talent with Endpoints Careers
Contact Meg Estacio: mestacio@endpointsnews.com